Top Biotech Companies (3,709)
Caprion Biosciences was a leading provider of proteomics and immune monitoring services to the pharmaceutical and biotechnology industry, specializing in advanced immunology and proteomics services. It has since rebranded to CellCarta, a global contract research organization.
INVO Fertility, Inc. is a healthcare services company dedicated to expanding access to assisted reproductive technology (ART) care. The company focuses on building, acquiring, and operating fertility clinics, including its specialized 'INVO Centers.' Additionally, it develops and distributes the proprietary INVOcell medical device, which enables fertilization and early embryo development to occur in vivo within a woman's body, offering a...
SpotLab is an artificial intelligence company focused on healthcare, specializing in AI-driven solutions for clinical research and diagnosis assistance. The company develops technologies for diagnosis, prognosis, screening, and digital biomarkers discovery. Based in Madrid, Spain, SpotLab aims to improve healthcare accessibility by creating trustworthy AI tools for biopharma research and medical diagnostics, ensuring cutting-edge technology benefits everyone everywhere.
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows...
Caris Life Sciences was founded in 2008 with a simple but powerful purpose – to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of big data, we are revolutionizing healthcare to provide physicians and patients with the highest quality information about their disease – from detecting it early and determining how...
Caris Life Sciences's Top Stability & Growth Strengths
Strong Revenue Growth: Reported results indicate rapid top-line expansion through 2025 with continued momentum into early 2026 and reaffirmed guidance toward the billion‑dollar range. Feedback suggests this trajectory is anchored by rising therapy‑selection volumes and improving margins with positive adjusted EBITDA and cash generation noted.
Strategic Partnerships: A large, academically anchored Precision Oncology Alliance, deeper Epic EHR integration, and multiple biopharma collaborations provide distribution leverage and evidence‑generation capacity. These relationships appear to support broader adoption, data scale, and pipeline progression.
Innovation-Driven Growth: Routine WES/WTS and launches such as MI Cancer Seek (FDA‑approved WES/WTS‑based CDx), Caris Assure, and ChromoSeq, with Caris Detect planned, indicate a robust product and AI/ML innovation engine. This multi‑omic breadth differentiates clinical offerings and strengthens the company’s data and modeling assets.
Ketryx is the first and only connected application lifecycle management software for the life sciences industry. Our automation-based software enables companies building FDA-regulated software and AI-based applications to accelerate development through modern cloud-based tools while improving quality and compliance. Ketryx creates a real-time, and traceable, single source of truth by overlaying product development tools and connecting all items, risks, code,...
Genus is a world-leading animal genetics company. At the forefront of innovation in gene-editing, advanced reproductive biology, and other breakthrough breeding technologies, Genus R&D advances an agricultural practice thousands of years old – animal breeding. Our goal is to ensure the global food system continues to nurture healthy, productive animals that yield affordable, high-quality proteins for a sustainable future. We believe...
Founded in 1995, Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples. MSD’s proprietary MULTI ARRAY technology enhances medical research and drug development by enabling researchers to profile many biomarkers simultaneously in a single sample without compromising assay performance. MSD’s technology has...
OneStudyTeam, a member of the Reify Health family, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients,...
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing...
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. We bring our nutrient-rich, all-natural krill ingredient to the pharmaceutical and nutraceutical markets through our leading brands: Superba Krill Oil, Lysoveta, Understory, and Kori Krill. Our innovative approach also extends into our spin-offs FloraMarine (plant-based source of omega-3 from algae), AION...
Orakl Oncology is a techbio startup and precision oncology company that combines cutting-edge biology and AI to accelerate cancer drug discovery and development. Utilizing an innovative predictive engine and one of the world's largest collections of patient tumor avatars, the company aims to de-risk clinical trials, identify new drug targets, and expand the therapeutic arsenal available to cancer patients.
UCF Clinical LLC, operating under the UCF Health brand, is part of the University of Central Florida's Academic Health Sciences Center. It provides comprehensive primary and specialty healthcare services to the general public in East Orlando and Lake Nona, Florida. The organization integrates various clinical programs and conducts extensive medical and clinical research, including FDA-regulated drug and device clinical trials...
In today's interconnected world, we are currently faced with many global challenges and opportunities surrounding infectious diseases. At Alveo, we're tackling these head-on by creating technology platforms that provide rapid, reliable, and economical cloud-based diagnostics for use by everyone, anytime, everywhere.
Refeyn, the pioneer of mass photometry, is delivering a disruptive new generation of analytical instruments that let you weigh individual molecules with light. Mass photometry offers new possibilities to characterise the function, structural composition and dynamics of biomolecules. Refeyn instruments measure the mass of individual molecules directly in solution, rapidly, and simply, revealing the true behaviour of molecules in near-native...
Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across...
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Asimov's Top Stability & Growth Strengths
Strategic Partnerships: Meaningful partnerships with blue‑chip players (e.g., Cytiva, LOTTE Biologics, Novo Nordisk, AGC Biologics) signal third‑party validation and channels for broader adoption of its platform.
Product Line Growth: Product launches and updates across CHO Edge, LV Edge, and AAV Edge (including stable AAV producer cell lines and CHO Edge Rapid Pools) indicate an expanding offering aimed at biologics and gene therapy workflows.
Investor Backing & Capital Strength: Raising over $200M provides financial runway to scale R&D and commercialization and supports continued platform build‑out through 2024–2026.
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company dedicated to discovering and developing innovative, novel precision cancer medicines for underserved patients. The company focuses on targeting key drivers of cancer cell growth and resistance, with a pipeline that includes JAK2V617F and KAT6A programs and degrader antibody conjugates to treat various cancers, including breast cancer and myeloproliferative neoplasms.
Civia Health is a clinical study network and digital platform that specializes in high-performance site management and patient recruitment for chronic ambulatory conditions. The company operates retail-based research sites and a participant registry, Thrive with Civia, to streamline recruitment using AI-enabled tools, aiming to make clinical trials more accessible and human-centered for underrepresented communities.















_0.jpg)

















